| 0 |
RHIZOBIUM RADIOBACTER BACTERAEMIA |
13 |
0.8667 |
| 1 |
ACTINOMYCOTIC SEPSIS |
18 |
0.7200 |
| 2 |
CYTOMEGALOVIRUS URINARY TRACT INFECTION |
20 |
0.6452 |
| 3 |
SERTOLI-CELL-ONLY SYNDROME |
9 |
0.6000 |
| 4 |
OVARIAN ATROPHY |
27 |
0.3176 |
| 5 |
DONOR LEUKOCYTE INFUSION |
8 |
0.3077 |
| 6 |
OVARIAN DYSFUNCTION |
15 |
0.3000 |
| 7 |
VIRAL HAEMORRHAGIC CYSTITIS |
205 |
0.2879 |
| 8 |
CYSTITIS VIRAL |
99 |
0.2585 |
| 9 |
PRIMARY HYPOGONADISM |
38 |
0.2420 |
| 10 |
DISSEMINATED TOXOPLASMOSIS |
29 |
0.2417 |
| 11 |
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME |
14 |
0.2373 |
| 12 |
BRONCHIOLITIS OBLITERANS SYNDROME |
39 |
0.2229 |
| 13 |
IDIOPATHIC PNEUMONIA SYNDROME |
65 |
0.2181 |
| 14 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
599 |
0.2165 |
| 15 |
CHIMERISM |
19 |
0.2135 |
| 16 |
VENOOCCLUSIVE DISEASE |
533 |
0.2127 |
| 17 |
CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE |
39 |
0.2053 |
| 18 |
RETINOPATHY HAEMORRHAGIC |
13 |
0.1970 |
| 19 |
ENGRAFT FAILURE |
55 |
0.1916 |
| 20 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
264 |
0.1868 |
| 21 |
ACUTE GRAFT VERSUS HOST DISEASE |
832 |
0.1816 |
| 22 |
VENOOCCLUSIVE LIVER DISEASE |
888 |
0.1796 |
| 23 |
HYPERFIBRINOGENAEMIA |
12 |
0.1791 |
| 24 |
CHRONIC GRAFT VERSUS HOST DISEASE |
645 |
0.1785 |
| 25 |
HEART FAILURE WITH MIDRANGE EJECTION FRACTION |
10 |
0.1695 |
| 26 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
120 |
0.1669 |
| 27 |
VIRURIA |
18 |
0.1667 |
| 28 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
354 |
0.1662 |
| 29 |
GRAFT VERSUS HOST DISEASE IN SKIN |
366 |
0.1660 |
| 30 |
RETINITIS VIRAL |
20 |
0.1653 |
| 31 |
IATROGENIC KAPOSI SARCOMA |
8 |
0.1633 |
| 32 |
ELECTROCARDIOGRAM T WAVE BIPHASIC |
9 |
0.1607 |
| 33 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
147 |
0.1587 |
| 34 |
STENOTROPHOMONAS BACTERAEMIA |
12 |
0.1579 |
| 35 |
ENGRAFTMENT SYNDROME |
93 |
0.1574 |
| 36 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
199 |
0.1511 |
| 37 |
CHRONIC GRAFT VERSUS HOST DISEASE IN EYE |
30 |
0.1478 |
| 38 |
ARTERITIS INFECTIVE |
9 |
0.1475 |
| 39 |
BONE MARROW TRANSPLANT REJECTION |
31 |
0.1409 |
| 40 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
619 |
0.1400 |
| 41 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER |
50 |
0.1374 |
| 42 |
UPPER RESPIRATORY FUNGAL INFECTION |
26 |
0.1368 |
| 43 |
SHORT STATURE |
34 |
0.1298 |
| 44 |
GRAFT VERSUS HOST DISEASE |
922 |
0.1281 |
| 45 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
46 |
0.1274 |
| 46 |
HERPES ZOSTER INFECTION NEUROLOGICAL |
20 |
0.1258 |
| 47 |
PRE-ENGRAFTMENT IMMUNE REACTION |
10 |
0.1250 |
| 48 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
267 |
0.1242 |
| 49 |
ACQUIRED MACROGLOSSIA |
11 |
0.1236 |
| 50 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
30 |
0.1224 |
| 51 |
LACTOBACILLUS INFECTION |
20 |
0.1220 |
| 52 |
BLOOD STEM CELL TRANSPLANT FAILURE |
26 |
0.1209 |
| 53 |
HUMAN POLYOMAVIRUS INFECTION |
64 |
0.1205 |
| 54 |
SERRATIA SEPSIS |
13 |
0.1204 |
| 55 |
ADENOVIRAL HEPATITIS |
28 |
0.1191 |
| 56 |
OVARIAN FAILURE |
63 |
0.1178 |
| 57 |
BK VIRUS INFECTION |
391 |
0.1158 |
| 58 |
CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG |
20 |
0.1156 |
| 59 |
ALLOGENIC STEM CELL TRANSPLANTATION |
18 |
0.1139 |
| 60 |
MENINGITIS ENTEROCOCCAL |
9 |
0.1139 |
| 61 |
POIKILODERMA |
12 |
0.1111 |
| 62 |
CYSTITIS HAEMORRHAGIC |
442 |
0.1095 |
| 63 |
LARYNGITIS FUNGAL |
14 |
0.1085 |
| 64 |
GASTRITIS FUNGAL |
11 |
0.1068 |
| 65 |
SPINAL INSTABILITY |
27 |
0.1063 |
| 66 |
ADENOVIRUS REACTIVATION |
15 |
0.1042 |
| 67 |
HEPATIC VEIN OCCLUSION |
16 |
0.1013 |
| 68 |
GRAFT VERSUS HOST DISEASE IN LIVER |
72 |
0.1006 |
| 69 |
ENCEPHALITIS CYTOMEGALOVIRUS |
43 |
0.0982 |
| 70 |
TOOTH HYPOPLASIA |
17 |
0.0977 |
| 71 |
CONGENITAL APLASIA |
30 |
0.0965 |
| 72 |
TRANSPLANT FAILURE |
228 |
0.0929 |
| 73 |
ORAL LICHENOID REACTION |
10 |
0.0917 |
| 74 |
REFRACTORINESS TO PLATELET TRANSFUSION |
10 |
0.0917 |
| 75 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
25 |
0.0880 |
| 76 |
HERPES SIMPLEX VIRAEMIA |
11 |
0.0880 |
| 77 |
CYTOMEGALOVIRUS ANTIGEN POSITIVE |
16 |
0.0874 |
| 78 |
HUMAN HERPESVIRUS 6 INFECTION REACTIVATION |
30 |
0.0855 |
| 79 |
BK POLYOMAVIRUS TEST POSITIVE |
8 |
0.0833 |
| 80 |
MENINGITIS TUBERCULOUS |
46 |
0.0823 |
| 81 |
GRAFT VERSUS HOST DISEASE IN EYE |
19 |
0.0823 |
| 82 |
TOXIC ERYTHEMA OF CHEMOTHERAPY |
21 |
0.0811 |
| 83 |
HUMAN HERPESVIRUS 6 INFECTION |
149 |
0.0788 |
| 84 |
GRAFT VERSUS HOST DISEASE IN LUNG |
37 |
0.0774 |
| 85 |
BLOOD LUTEINISING HORMONE INCREASED |
19 |
0.0772 |
| 86 |
GRAFT VERSUS HOST DISEASE IN INTESTINE |
10 |
0.0769 |
| 87 |
ADENOVIRUS INFECTION |
222 |
0.0765 |
| 88 |
EPSTEIN-BARR VIRAEMIA |
83 |
0.0748 |
| 89 |
CEREBRAL TOXOPLASMOSIS |
69 |
0.0739 |
| 90 |
OBLITERATIVE BRONCHIOLITIS |
95 |
0.0724 |
| 91 |
CYTOMEGALOVIRUS VIRAEMIA |
319 |
0.0716 |
| 92 |
PARASPINAL ABSCESS |
11 |
0.0710 |
| 93 |
TOXOPLASMOSIS |
73 |
0.0676 |
| 94 |
ENTEROBACTER SEPSIS |
25 |
0.0676 |
| 95 |
POST TRANSPLANT DISTAL LIMB SYNDROME |
13 |
0.0640 |
| 96 |
ADENOMATOUS POLYPOSIS COLI |
9 |
0.0638 |
| 97 |
ACANTHAMOEBA INFECTION |
12 |
0.0638 |
| 98 |
GASTROENTERITIS ADENOVIRUS |
10 |
0.0637 |
| 99 |
RHINOCEREBRAL MUCORMYCOSIS |
22 |
0.0634 |
| 100 |
COLITIS EROSIVE |
10 |
0.0629 |
| 101 |
ENTEROBACTER BACTERAEMIA |
19 |
0.0627 |
| 102 |
ADENOVIRAL HAEMORRHAGIC CYSTITIS |
13 |
0.0625 |
| 103 |
POLYOMAVIRUS VIRAEMIA |
66 |
0.0621 |
| 104 |
ALTERNARIA INFECTION |
23 |
0.0618 |
| 105 |
PNEUMONIA CYTOMEGALOVIRAL |
120 |
0.0617 |
| 106 |
HEPATOSPLENIC CANDIDIASIS |
9 |
0.0612 |
| 107 |
DISSEMINATED MUCORMYCOSIS |
24 |
0.0609 |
| 108 |
PNEUMONIA ADENOVIRAL |
12 |
0.0606 |
| 109 |
MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS |
9 |
0.0588 |
| 110 |
JC VIRUS INFECTION |
93 |
0.0581 |
| 111 |
NODULAR MELANOMA |
10 |
0.0578 |
| 112 |
PREMATURE MENOPAUSE |
53 |
0.0574 |
| 113 |
TRANSPLANTATION COMPLICATION |
24 |
0.0571 |
| 114 |
RETICULOCYTOSIS |
12 |
0.0566 |
| 115 |
SWEAT GLAND TUMOUR |
13 |
0.0553 |
| 116 |
HYPOURICAEMIA |
16 |
0.0552 |
| 117 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
272 |
0.0534 |
| 118 |
CYTOMEGALOVIRUS INFECTION |
881 |
0.0530 |
| 119 |
ANTI-PLATELET ANTIBODY POSITIVE |
9 |
0.0520 |
| 120 |
PARENTERAL NUTRITION |
12 |
0.0519 |
| 121 |
EPSTEIN-BARR VIRUS INFECTION |
320 |
0.0512 |
| 122 |
BLOOD FOLLICLE STIMULATING HORMONE INCREASED |
20 |
0.0512 |
| 123 |
ENTEROCOCCAL BACTERAEMIA |
53 |
0.0500 |
| 124 |
GRAFT COMPLICATION |
29 |
0.0494 |
| 125 |
APLASTIC ANAEMIA |
256 |
0.0490 |
| 126 |
PULMONARY VENO-OCCLUSIVE DISEASE |
34 |
0.0486 |
| 127 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
8 |
0.0465 |
| 128 |
CYTOMEGALOVIRUS TEST POSITIVE |
82 |
0.0460 |
| 129 |
DEVICE RELATED BACTERAEMIA |
14 |
0.0452 |
| 130 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
78 |
0.0441 |
| 131 |
LEUKAEMIA RECURRENT |
74 |
0.0437 |
| 132 |
INFECTION REACTIVATION |
50 |
0.0437 |
| 133 |
VASCULAR MALFORMATION |
9 |
0.0429 |
| 134 |
MUCOSAL INFLAMMATION |
1121 |
0.0428 |
| 135 |
MENINGOENCEPHALITIS HERPETIC |
19 |
0.0424 |
| 136 |
CENTRAL HYPOTHYROIDISM |
14 |
0.0423 |
| 137 |
KLEBSIELLA BACTERAEMIA |
39 |
0.0411 |
| 138 |
SYSTEMIC MYCOSIS |
47 |
0.0402 |
| 139 |
HERPES SIMPLEX TEST POSITIVE |
8 |
0.0402 |
| 140 |
CELLULITIS STAPHYLOCOCCAL |
26 |
0.0399 |
| 141 |
STENOTROPHOMONAS INFECTION |
54 |
0.0398 |
| 142 |
ENTEROCOLITIS VIRAL |
12 |
0.0395 |
| 143 |
CYTOMEGALOVIRUS CHORIORETINITIS |
77 |
0.0394 |
| 144 |
TRANSPLANT DYSFUNCTION |
70 |
0.0392 |
| 145 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
101 |
0.0391 |
| 146 |
THROMBOTIC MICROANGIOPATHY |
378 |
0.0387 |
| 147 |
CHLOROMA |
16 |
0.0379 |
| 148 |
RESPIRATORY TRACT INFECTION FUNGAL |
20 |
0.0379 |
| 149 |
RENAL TUBULAR INJURY |
46 |
0.0379 |
| 150 |
ENCEPHALITIS VIRAL |
46 |
0.0378 |
| 151 |
NEUTROPENIC INFECTION |
36 |
0.0376 |
| 152 |
CYTOMEGALOVIRUS GASTROENTERITIS |
8 |
0.0370 |
| 153 |
MUCORMYCOSIS |
96 |
0.0369 |
| 154 |
FOCAL NODULAR HYPERPLASIA |
19 |
0.0365 |
| 155 |
KLEBSIELLA SEPSIS |
40 |
0.0355 |
| 156 |
COOMBS DIRECT TEST POSITIVE |
11 |
0.0353 |
| 157 |
ENAMEL ANOMALY |
10 |
0.0350 |
| 158 |
KLEBSIELLA URINARY TRACT INFECTION |
9 |
0.0340 |
| 159 |
CANDIDA SEPSIS |
30 |
0.0334 |
| 160 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
13 |
0.0334 |
| 161 |
VARICELLA ZOSTER VIRUS INFECTION |
69 |
0.0333 |
| 162 |
RESTRICTIVE CARDIOMYOPATHY |
10 |
0.0330 |
| 163 |
PRIMARY ADRENAL INSUFFICIENCY |
10 |
0.0328 |
| 164 |
GROWTH HORMONE DEFICIENCY |
13 |
0.0327 |
| 165 |
DEMYELINATING POLYNEUROPATHY |
33 |
0.0321 |
| 166 |
GASTROINTESTINAL MUCOSAL DISORDER |
21 |
0.0321 |
| 167 |
CEREBRAL FUNGAL INFECTION |
9 |
0.0318 |
| 168 |
CYTOMEGALOVIRUS GASTRITIS |
8 |
0.0316 |
| 169 |
CYTOMEGALOVIRUS ENTERITIS |
11 |
0.0309 |
| 170 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
293 |
0.0307 |
| 171 |
BACTERIAL SEPSIS |
96 |
0.0294 |
| 172 |
VENOUS HAEMORRHAGE |
9 |
0.0290 |
| 173 |
HERPES SIMPLEX REACTIVATION |
11 |
0.0289 |
| 174 |
POLYSEROSITIS |
12 |
0.0282 |
| 175 |
METAPNEUMOVIRUS INFECTION |
22 |
0.0281 |
| 176 |
MYCOBACTERIUM HAEMOPHILUM INFECTION |
8 |
0.0280 |
| 177 |
BRONCHOPULMONARY ASPERGILLOSIS |
217 |
0.0280 |
| 178 |
PSEUDOMONAL SEPSIS |
49 |
0.0280 |
| 179 |
HYPERFERRITINAEMIA |
12 |
0.0278 |
| 180 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
9 |
0.0278 |
| 181 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
95 |
0.0277 |
| 182 |
ANGIODYSPLASIA |
10 |
0.0275 |
| 183 |
BLADDER HYPERTROPHY |
12 |
0.0271 |
| 184 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
25 |
0.0270 |
| 185 |
ACIDOSIS HYPERCHLORAEMIC |
16 |
0.0269 |
| 186 |
DYSBIOSIS |
22 |
0.0268 |
| 187 |
BLADDER TAMPONADE |
8 |
0.0264 |
| 188 |
EVANS SYNDROME |
13 |
0.0264 |
| 189 |
VIRAL DIARRHOEA |
9 |
0.0262 |
| 190 |
CORNEAL LESION |
8 |
0.0260 |
| 191 |
SYSTEMIC CANDIDA |
65 |
0.0259 |
| 192 |
FUSARIUM INFECTION |
18 |
0.0257 |
| 193 |
SINUSITIS FUNGAL |
20 |
0.0249 |
| 194 |
GLOMERULONEPHRITIS MINIMAL LESION |
18 |
0.0248 |
| 195 |
MICROANGIOPATHY |
23 |
0.0245 |
| 196 |
PNEUMONIA KLEBSIELLA |
45 |
0.0245 |
| 197 |
STEM CELL TRANSPLANT |
61 |
0.0244 |
| 198 |
HERPES SIMPLEX |
157 |
0.0241 |
| 199 |
CHRONIC MYELOID LEUKAEMIA RECURRENT |
13 |
0.0238 |
| 200 |
DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION |
11 |
0.0236 |
| 201 |
ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED |
8 |
0.0234 |
| 202 |
CAPILLARY LEAK SYNDROME |
48 |
0.0232 |
| 203 |
ENTEROCOCCAL INFECTION |
112 |
0.0232 |
| 204 |
BACTERAEMIA |
275 |
0.0231 |
| 205 |
SERRATIA INFECTION |
17 |
0.0228 |
| 206 |
COMPLICATIONS OF TRANSPLANT SURGERY |
11 |
0.0218 |
| 207 |
DIFFUSE ALVEOLAR DAMAGE |
25 |
0.0217 |
| 208 |
SPLENIC VEIN THROMBOSIS |
11 |
0.0217 |
| 209 |
FUNGAL SEPSIS |
18 |
0.0217 |
| 210 |
FAT NECROSIS |
13 |
0.0214 |
| 211 |
CEREBRAL ARTERY THROMBOSIS |
11 |
0.0214 |
| 212 |
GROWTH RETARDATION |
63 |
0.0214 |
| 213 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
18 |
0.0214 |
| 214 |
PNEUMONIA FUNGAL |
84 |
0.0213 |
| 215 |
SCEDOSPORIUM INFECTION |
15 |
0.0212 |
| 216 |
STREPTOCOCCAL BACTERAEMIA |
23 |
0.0211 |
| 217 |
ROTAVIRUS INFECTION |
12 |
0.0208 |
| 218 |
CRANIAL NERVE DISORDER |
14 |
0.0200 |
| 219 |
KLEBSIELLA INFECTION |
101 |
0.0200 |
| 220 |
PARVOVIRUS INFECTION |
8 |
0.0198 |
| 221 |
CEREBRAL ASPERGILLOSIS |
12 |
0.0195 |
| 222 |
RED BLOOD CELL TRANSFUSION |
8 |
0.0195 |
| 223 |
LICHENIFICATION |
8 |
0.0195 |
| 224 |
BONE MARROW TOXICITY |
23 |
0.0194 |
| 225 |
STEROID DEPENDENCE |
17 |
0.0194 |
| 226 |
NEUTROPENIC COLITIS |
40 |
0.0193 |
| 227 |
ANAEMIA HAEMOLYTIC AUTOIMMUNE |
16 |
0.0193 |
| 228 |
MYCOPLASMA INFECTION |
15 |
0.0192 |
| 229 |
SMOOTH MUSCLE CELL NEOPLASM |
8 |
0.0191 |
| 230 |
FUNGAEMIA |
30 |
0.0190 |
| 231 |
PERICARDITIS CONSTRICTIVE |
8 |
0.0190 |
| 232 |
HYPERPLASIA |
17 |
0.0189 |
| 233 |
MYELITIS |
29 |
0.0187 |
| 234 |
HAPTOGLOBIN DECREASED |
15 |
0.0186 |
| 235 |
RETICULOCYTE COUNT INCREASED |
15 |
0.0185 |
| 236 |
APLASIA |
36 |
0.0184 |
| 237 |
PANCREATIC ATROPHY |
8 |
0.0183 |
| 238 |
ENCEPHALITIS HERPES |
9 |
0.0182 |
| 239 |
SEROSITIS |
10 |
0.0181 |
| 240 |
VIRAEMIA |
25 |
0.0180 |
| 241 |
SEPTIC EMBOLUS |
15 |
0.0180 |
| 242 |
PARVOVIRUS B19 INFECTION |
16 |
0.0179 |
| 243 |
GLOMERULONEPHRITIS MEMBRANOUS |
21 |
0.0179 |
| 244 |
ESCHERICHIA BACTERAEMIA |
42 |
0.0178 |
| 245 |
PARAINFLUENZAE VIRUS INFECTION |
27 |
0.0177 |
| 246 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
146 |
0.0177 |
| 247 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
8 |
0.0174 |
| 248 |
HYPOTHALAMO-PITUITARY DISORDER |
25 |
0.0172 |
| 249 |
STAPHYLOCOCCAL SEPSIS |
82 |
0.0166 |
| 250 |
MINIMAL RESIDUAL DISEASE |
8 |
0.0166 |
| 251 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
12 |
0.0165 |
| 252 |
NEOPLASM RECURRENCE |
56 |
0.0165 |
| 253 |
SUPERINFECTION BACTERIAL |
13 |
0.0164 |
| 254 |
PULMONARY HAEMORRHAGE |
127 |
0.0162 |
| 255 |
RHINOVIRUS INFECTION |
63 |
0.0162 |
| 256 |
ASPERGILLOSIS |
21 |
0.0161 |
| 257 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
23 |
0.0160 |
| 258 |
ESCHERICHIA TEST POSITIVE |
19 |
0.0159 |
| 259 |
ASPERGILLUS INFECTION |
103 |
0.0157 |
| 260 |
EXTREMITY CONTRACTURE |
10 |
0.0156 |
| 261 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
16 |
0.0156 |
| 262 |
PLATELET TRANSFUSION |
20 |
0.0155 |
| 263 |
GASTROINTESTINAL TOXICITY |
74 |
0.0154 |
| 264 |
CRYPTOSPORIDIOSIS INFECTION |
8 |
0.0152 |
| 265 |
PNEUMOCOCCAL SEPSIS |
10 |
0.0152 |
| 266 |
ALVEOLAR PROTEINOSIS |
9 |
0.0152 |
| 267 |
GASTRIC MUCOSAL LESION |
11 |
0.0151 |
| 268 |
CORYNEBACTERIUM INFECTION |
8 |
0.0150 |
| 269 |
CUSHINGOID |
48 |
0.0149 |
| 270 |
ENTEROCOCCAL SEPSIS |
12 |
0.0148 |
| 271 |
HUMAN HERPESVIRUS 8 INFECTION |
9 |
0.0148 |
| 272 |
BLOOD BILIRUBIN DECREASED |
9 |
0.0146 |
| 273 |
HEPATOBILIARY DISEASE |
9 |
0.0144 |
| 274 |
ADRENAL HAEMORRHAGE |
8 |
0.0143 |
| 275 |
BACILLUS INFECTION |
9 |
0.0142 |
| 276 |
STAPHYLOCOCCAL BACTERAEMIA |
61 |
0.0140 |
| 277 |
DIARRHOEA INFECTIOUS |
11 |
0.0140 |
| 278 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
11 |
0.0140 |
| 279 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
143 |
0.0139 |
| 280 |
BLOOD IMMUNOGLOBULIN A DECREASED |
9 |
0.0138 |
| 281 |
KLEBSIELLA TEST POSITIVE |
9 |
0.0138 |
| 282 |
PULMONARY ALVEOLAR HAEMORRHAGE |
77 |
0.0137 |
| 283 |
HILAR LYMPHADENOPATHY |
12 |
0.0136 |
| 284 |
STREPTOCOCCAL SEPSIS |
16 |
0.0135 |
| 285 |
CYTOMEGALOVIRUS COLITIS |
31 |
0.0135 |
| 286 |
FEBRILE NEUTROPENIA |
886 |
0.0133 |
| 287 |
ACUTE MYELOID LEUKAEMIA |
206 |
0.0132 |
| 288 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
35 |
0.0131 |
| 289 |
SURGICAL PROCEDURE REPEATED |
9 |
0.0131 |
| 290 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
10 |
0.0130 |
| 291 |
HYPOGAMMAGLOBULINAEMIA |
85 |
0.0129 |
| 292 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
97 |
0.0129 |
| 293 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
366 |
0.0129 |
| 294 |
URINARY TRACT INFECTION BACTERIAL |
32 |
0.0126 |
| 295 |
BRAIN ABSCESS |
32 |
0.0126 |
| 296 |
PNEUMONIA INFLUENZAL |
15 |
0.0126 |
| 297 |
NOCARDIOSIS |
32 |
0.0125 |
| 298 |
ENDOCRINE DISORDER |
16 |
0.0125 |
| 299 |
TRANSPLANT REJECTION |
100 |
0.0125 |
| 300 |
HERPES ZOSTER DISSEMINATED |
10 |
0.0125 |
| 301 |
CLOSTRIDIUM DIFFICILE COLITIS |
132 |
0.0124 |
| 302 |
BONE MARROW DEPRESSION |
12 |
0.0123 |
| 303 |
IMMUNE THROMBOCYTOPENIA |
56 |
0.0122 |
| 304 |
BONE MARROW TRANSPLANT |
23 |
0.0121 |
| 305 |
GASTROENTERITIS NOROVIRUS |
16 |
0.0120 |
| 306 |
CAMPYLOBACTER INFECTION |
10 |
0.0120 |
| 307 |
SKIN TOXICITY |
68 |
0.0120 |
| 308 |
HEPATIC NECROSIS |
45 |
0.0119 |
| 309 |
MUCOSAL ULCERATION |
12 |
0.0119 |
| 310 |
DISSEMINATED CRYPTOCOCCOSIS |
9 |
0.0119 |
| 311 |
ACINETOBACTER INFECTION |
13 |
0.0119 |
| 312 |
HEPATORENAL SYNDROME |
20 |
0.0118 |
| 313 |
GLYCOSURIA |
16 |
0.0118 |
| 314 |
PSEUDOMONAL BACTERAEMIA |
10 |
0.0117 |
| 315 |
VANISHING BILE DUCT SYNDROME |
13 |
0.0117 |
| 316 |
BONE MARROW FAILURE |
235 |
0.0116 |
| 317 |
SOFT TISSUE INFECTION |
21 |
0.0115 |
| 318 |
GUILLAIN-BARRE SYNDROME |
55 |
0.0114 |
| 319 |
PELVIC FLUID COLLECTION |
8 |
0.0113 |
| 320 |
BLAST CRISIS IN MYELOGENOUS LEUKAEMIA |
14 |
0.0113 |
| 321 |
ENTEROBACTER INFECTION |
19 |
0.0113 |
| 322 |
LYMPHOPROLIFERATIVE DISORDER |
33 |
0.0112 |
| 323 |
PNEUMATOSIS INTESTINALIS |
32 |
0.0112 |
| 324 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
9 |
0.0111 |
| 325 |
GRAFT LOSS |
8 |
0.0110 |
| 326 |
ESCHERICHIA SEPSIS |
32 |
0.0110 |
| 327 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
67 |
0.0110 |
| 328 |
LYMPH NODE TUBERCULOSIS |
8 |
0.0108 |
| 329 |
LUNG CONSOLIDATION |
30 |
0.0107 |
| 330 |
PNEUMONIA STAPHYLOCOCCAL |
21 |
0.0106 |
| 331 |
PULMONARY TOXICITY |
74 |
0.0105 |
| 332 |
PSEUDOMONAS INFECTION |
89 |
0.0104 |
| 333 |
EPIDIDYMITIS |
12 |
0.0103 |
| 334 |
MENINGITIS CRYPTOCOCCAL |
18 |
0.0103 |
| 335 |
ADENOCARCINOMA PANCREAS |
13 |
0.0101 |
| 336 |
HEPATITIS B REACTIVATION |
32 |
0.0101 |
| 337 |
MUCOSAL DISORDER |
10 |
0.0101 |
| 338 |
AUTOIMMUNE THYROIDITIS |
38 |
0.0100 |
| 339 |
BLOOD CULTURE POSITIVE |
30 |
0.0100 |
| 340 |
HYPOPROTEINAEMIA |
19 |
0.0100 |
| 341 |
HEART TRANSPLANT |
9 |
0.0099 |
| 342 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
15 |
0.0099 |
| 343 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
172 |
0.0097 |
| 344 |
WHITE MATTER LESION |
12 |
0.0095 |
| 345 |
ACTINOMYCOSIS |
9 |
0.0094 |
| 346 |
HAEMATOTOXICITY |
89 |
0.0094 |
| 347 |
MYELODYSPLASTIC SYNDROME |
135 |
0.0093 |
| 348 |
DRUG CLEARANCE DECREASED |
12 |
0.0092 |
| 349 |
NEPHROPATHY TOXIC |
103 |
0.0092 |
| 350 |
SPINAL CORD DISORDER |
15 |
0.0091 |
| 351 |
STAPHYLOCOCCUS TEST POSITIVE |
19 |
0.0090 |
| 352 |
NOROVIRUS INFECTION |
13 |
0.0090 |
| 353 |
APLASIA PURE RED CELL |
31 |
0.0090 |
| 354 |
VITILIGO |
21 |
0.0089 |
| 355 |
PNEUMONIA VIRAL |
28 |
0.0088 |
| 356 |
HISTIOCYTOSIS HAEMATOPHAGIC |
26 |
0.0087 |
| 357 |
PORTAL HYPERTENSION |
27 |
0.0087 |
| 358 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
87 |
0.0087 |
| 359 |
MYELITIS TRANSVERSE |
12 |
0.0085 |
| 360 |
ACTINIC KERATOSIS |
22 |
0.0085 |
| 361 |
PNEUMOCYSTIS JIROVECII INFECTION |
10 |
0.0084 |
| 362 |
LEUKOENCEPHALOPATHY |
31 |
0.0083 |
| 363 |
ORGANISING PNEUMONIA |
41 |
0.0083 |
| 364 |
ESCHERICHIA INFECTION |
68 |
0.0083 |
| 365 |
HEPATOMEGALY |
81 |
0.0082 |
| 366 |
PANCYTOPENIA |
459 |
0.0082 |
| 367 |
BACTERIAL INFECTION |
153 |
0.0082 |
| 368 |
HYPERBILIRUBINAEMIA |
84 |
0.0081 |
| 369 |
BLOOD IMMUNOGLOBULIN M DECREASED |
8 |
0.0080 |
| 370 |
PNEUMONIA BACTERIAL |
73 |
0.0079 |
| 371 |
CORTISOL DECREASED |
9 |
0.0079 |
| 372 |
GASTROINTESTINAL BACTERIAL INFECTION |
9 |
0.0079 |
| 373 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
30 |
0.0078 |
| 374 |
FANCONI SYNDROME |
11 |
0.0078 |
| 375 |
CARDIOTOXICITY |
69 |
0.0077 |
| 376 |
LIP ULCERATION |
9 |
0.0077 |
| 377 |
PULMONARY FUNCTION TEST ABNORMAL |
12 |
0.0077 |
| 378 |
ENCEPHALITIS |
53 |
0.0077 |
| 379 |
RECURRENT CANCER |
31 |
0.0076 |
| 380 |
CYTOPENIA |
93 |
0.0076 |
| 381 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
12 |
0.0075 |
| 382 |
HAEMORRHAGE URINARY TRACT |
19 |
0.0075 |
| 383 |
MULTIPLE-DRUG RESISTANCE |
23 |
0.0074 |
| 384 |
PHARYNGEAL INFLAMMATION |
9 |
0.0074 |
| 385 |
NEUROLOGICAL DECOMPENSATION |
17 |
0.0073 |
| 386 |
MULTI-ORGAN FAILURE |
125 |
0.0072 |
| 387 |
URINARY TRACT OBSTRUCTION |
17 |
0.0072 |
| 388 |
LIP HAEMORRHAGE |
9 |
0.0071 |
| 389 |
SEPTIC SHOCK |
306 |
0.0070 |
| 390 |
CANDIDA INFECTION |
118 |
0.0070 |
| 391 |
PRODUCT USE IN UNAPPROVED INDICATION |
1727 |
0.0070 |
| 392 |
CARDIAC TAMPONADE |
33 |
0.0069 |
| 393 |
HERPES OPHTHALMIC |
9 |
0.0068 |
| 394 |
PARAPARESIS |
12 |
0.0067 |
| 395 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
19 |
0.0067 |
| 396 |
BRAIN HERNIATION |
20 |
0.0067 |
| 397 |
RESPIRATORY FAILURE |
487 |
0.0067 |
| 398 |
LONG QT SYNDROME |
16 |
0.0067 |
| 399 |
DISSEMINATED TUBERCULOSIS |
17 |
0.0066 |
| 400 |
VENOUS THROMBOSIS |
26 |
0.0066 |
| 401 |
GENE MUTATION |
13 |
0.0066 |
| 402 |
LICHENOID KERATOSIS |
15 |
0.0066 |
| 403 |
NEUROTOXICITY |
114 |
0.0065 |
| 404 |
SECOND PRIMARY MALIGNANCY |
54 |
0.0065 |
| 405 |
ASCITES |
189 |
0.0064 |
| 406 |
FEBRILE BONE MARROW APLASIA |
27 |
0.0063 |
| 407 |
HAEMATOLOGICAL MALIGNANCY |
18 |
0.0063 |
| 408 |
BACTERIAL TEST POSITIVE |
14 |
0.0063 |
| 409 |
LYMPHADENOPATHY MEDIASTINAL |
12 |
0.0063 |
| 410 |
BLOOD BILIRUBIN ABNORMAL |
8 |
0.0062 |
| 411 |
HEPATOSPLENOMEGALY |
16 |
0.0062 |
| 412 |
PERICARDIAL EFFUSION |
144 |
0.0062 |
| 413 |
VASCULAR DEVICE INFECTION |
28 |
0.0062 |
| 414 |
HAEMATOLOGICAL INFECTION |
15 |
0.0061 |
| 415 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
16 |
0.0061 |
| 416 |
DEVICE RELATED INFECTION |
94 |
0.0061 |
| 417 |
PNEUMONIA PNEUMOCOCCAL |
9 |
0.0061 |
| 418 |
CERVICAL DYSPLASIA |
13 |
0.0059 |
| 419 |
STAPHYLOCOCCAL INFECTION |
194 |
0.0059 |
| 420 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
8 |
0.0058 |
| 421 |
MYCOBACTERIAL INFECTION |
10 |
0.0058 |
| 422 |
NEOPLASM SKIN |
9 |
0.0058 |
| 423 |
PERIPHERAL MOTOR NEUROPATHY |
8 |
0.0057 |
| 424 |
LUNG OPACITY |
15 |
0.0057 |
| 425 |
TRAUMATIC LUNG INJURY |
11 |
0.0057 |
| 426 |
END STAGE RENAL DISEASE |
103 |
0.0056 |
| 427 |
DRUG RESISTANCE |
145 |
0.0056 |
| 428 |
MYELOFIBROSIS |
17 |
0.0056 |
| 429 |
GASTROINTESTINAL INJURY |
15 |
0.0056 |
| 430 |
ENTEROCOLITIS |
32 |
0.0055 |
| 431 |
SUBDURAL HAEMORRHAGE |
15 |
0.0055 |
| 432 |
TRANSFUSION |
57 |
0.0054 |
| 433 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
12 |
0.0054 |
| 434 |
HAEMOLYSIS |
41 |
0.0053 |
| 435 |
MYELOPATHY |
10 |
0.0053 |
| 436 |
BRONCHIECTASIS |
35 |
0.0052 |
| 437 |
THROMBOCYTOPENIA |
577 |
0.0052 |
| 438 |
POLYMYOSITIS |
9 |
0.0051 |
| 439 |
PULMONARY HYPERTENSION |
105 |
0.0050 |
| 440 |
IMMUNE THROMBOCYTOPENIC PURPURA |
14 |
0.0049 |
| 441 |
PORTAL VEIN THROMBOSIS |
16 |
0.0049 |
| 442 |
RESPIRATORY ALKALOSIS |
8 |
0.0049 |
| 443 |
RIGHT VENTRICULAR FAILURE |
34 |
0.0048 |
| 444 |
DIFFUSE ALOPECIA |
9 |
0.0048 |
| 445 |
SEPSIS |
540 |
0.0048 |
| 446 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
17 |
0.0048 |
| 447 |
CYTOLYTIC HEPATITIS |
16 |
0.0048 |
| 448 |
RESPIRATORY DISTRESS |
132 |
0.0048 |
| 449 |
BLOOD BILIRUBIN INCREASED |
129 |
0.0048 |
| 450 |
LUNG ABSCESS |
10 |
0.0048 |
| 451 |
CHRONIC MYELOID LEUKAEMIA |
22 |
0.0048 |
| 452 |
SALMONELLOSIS |
8 |
0.0047 |
| 453 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
11 |
0.0047 |
| 454 |
HERPES VIRUS INFECTION |
27 |
0.0047 |
| 455 |
SHOCK HAEMORRHAGIC |
38 |
0.0047 |
| 456 |
PULMONARY INFARCTION |
11 |
0.0046 |
| 457 |
HEPATIC FAILURE |
140 |
0.0046 |
| 458 |
LUNG INFECTION |
72 |
0.0046 |
| 459 |
SKIN HYPERTROPHY |
13 |
0.0046 |
| 460 |
HEPATOTOXICITY |
103 |
0.0046 |
| 461 |
RENAL TUBULAR DISORDER |
13 |
0.0046 |
| 462 |
BRAIN NEOPLASM |
42 |
0.0046 |
| 463 |
FIBROSIS |
14 |
0.0045 |
| 464 |
BRONCHIOLITIS |
16 |
0.0045 |
| 465 |
NEPHROTIC SYNDROME |
31 |
0.0045 |
| 466 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
21 |
0.0044 |
| 467 |
LIVER TRANSPLANT |
16 |
0.0044 |
| 468 |
FUNGAL INFECTION |
146 |
0.0044 |
| 469 |
HYPOALBUMINAEMIA |
34 |
0.0044 |
| 470 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
38 |
0.0044 |
| 471 |
GASTROINTESTINAL INFECTION |
39 |
0.0043 |
| 472 |
OSTEOPENIA |
66 |
0.0043 |
| 473 |
DISSEMINATED INTRAVASCULAR COAGULATION |
61 |
0.0043 |
| 474 |
CARDIAC DYSFUNCTION |
16 |
0.0043 |
| 475 |
ORGAN FAILURE |
17 |
0.0042 |
| 476 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
21 |
0.0042 |
| 477 |
ARTHRITIS BACTERIAL |
17 |
0.0041 |
| 478 |
GASTROINTESTINAL NECROSIS |
12 |
0.0041 |
| 479 |
JUVENILE IDIOPATHIC ARTHRITIS |
10 |
0.0041 |
| 480 |
CLOSTRIDIUM TEST POSITIVE |
9 |
0.0041 |
| 481 |
HAEMORRHAGE INTRACRANIAL |
61 |
0.0041 |
| 482 |
LUNG INFILTRATION |
36 |
0.0041 |
| 483 |
PARESIS |
9 |
0.0040 |
| 484 |
HYPERAMMONAEMIA |
20 |
0.0040 |
| 485 |
COMPUTERISED TOMOGRAM ABNORMAL |
9 |
0.0040 |
| 486 |
GASTROINTESTINAL INFLAMMATION |
31 |
0.0040 |
| 487 |
NECROSIS |
22 |
0.0039 |
| 488 |
HEPATIC CYTOLYSIS |
50 |
0.0039 |
| 489 |
RASH MACULO-PAPULAR |
87 |
0.0039 |
| 490 |
THERAPEUTIC AGENT TOXICITY |
13 |
0.0039 |
| 491 |
PULMONARY ARTERIAL HYPERTENSION |
56 |
0.0039 |
| 492 |
INFECTION |
556 |
0.0038 |
| 493 |
LIVEDO RETICULARIS |
8 |
0.0038 |
| 494 |
STOMATITIS |
230 |
0.0038 |
| 495 |
VARICELLA |
9 |
0.0038 |
| 496 |
ATRIAL FLUTTER |
30 |
0.0038 |
| 497 |
PULMONARY TUBERCULOSIS |
16 |
0.0037 |
| 498 |
CANDIDIASIS |
15 |
0.0037 |
| 499 |
ENDOCARDITIS |
19 |
0.0037 |
| 500 |
HAEMODYNAMIC INSTABILITY |
28 |
0.0037 |
| 501 |
INTRACRANIAL PRESSURE INCREASED |
20 |
0.0036 |
| 502 |
COAGULOPATHY |
59 |
0.0035 |
| 503 |
BASAL CELL CARCINOMA |
54 |
0.0035 |
| 504 |
CATHETER SITE INFECTION |
13 |
0.0034 |
| 505 |
RESPIRATORY TRACT INFECTION VIRAL |
8 |
0.0034 |
| 506 |
THROMBOPHLEBITIS |
12 |
0.0034 |
| 507 |
PATHOGEN RESISTANCE |
31 |
0.0034 |
| 508 |
METASTASIS |
24 |
0.0034 |
| 509 |
HYPOVOLAEMIC SHOCK |
16 |
0.0033 |
| 510 |
CHOLESTASIS |
64 |
0.0033 |
| 511 |
LUNG ADENOCARCINOMA |
10 |
0.0033 |
| 512 |
LYMPHOPENIA |
47 |
0.0033 |
| 513 |
DIABETES INSIPIDUS |
8 |
0.0033 |
| 514 |
CACHEXIA |
17 |
0.0033 |
| 515 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
52 |
0.0033 |
| 516 |
NEUTROPENIA |
442 |
0.0032 |
| 517 |
HAEMOLYTIC ANAEMIA |
29 |
0.0032 |
| 518 |
INFLAMMATORY MARKER INCREASED |
16 |
0.0032 |
| 519 |
PNEUMOTHORAX |
51 |
0.0032 |
| 520 |
ATELECTASIS |
31 |
0.0032 |
| 521 |
NEUTROPHIL COUNT ABNORMAL |
9 |
0.0032 |
| 522 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
174 |
0.0032 |
| 523 |
DRUG TOXICITY |
43 |
0.0032 |
| 524 |
SPINAL STENOSIS |
13 |
0.0031 |
| 525 |
THERAPY PARTIAL RESPONDER |
49 |
0.0031 |
| 526 |
ORAL DISORDER |
23 |
0.0031 |
| 527 |
CONGESTIVE CARDIOMYOPATHY |
13 |
0.0031 |
| 528 |
PYELONEPHRITIS |
27 |
0.0031 |
| 529 |
FAILURE TO THRIVE |
16 |
0.0031 |
| 530 |
CARDIOPULMONARY FAILURE |
12 |
0.0031 |
| 531 |
ESCHERICHIA URINARY TRACT INFECTION |
13 |
0.0031 |
| 532 |
BONE LESION |
11 |
0.0030 |
| 533 |
URINE ANALYSIS ABNORMAL |
9 |
0.0030 |
| 534 |
BRAIN OEDEMA |
38 |
0.0030 |
| 535 |
SPLENOMEGALY |
35 |
0.0030 |
| 536 |
TOXIC SKIN ERUPTION |
30 |
0.0030 |
| 537 |
HAEMATURIA |
102 |
0.0030 |
| 538 |
ANAL ABSCESS |
16 |
0.0030 |
| 539 |
EMBOLISM VENOUS |
9 |
0.0030 |
| 540 |
TOXIC ENCEPHALOPATHY |
15 |
0.0030 |
| 541 |
CLOSTRIDIAL INFECTION |
10 |
0.0030 |
| 542 |
STATUS EPILEPTICUS |
33 |
0.0029 |
| 543 |
ACUTE RESPIRATORY FAILURE |
56 |
0.0029 |
| 544 |
GENERALISED OEDEMA |
36 |
0.0029 |
| 545 |
LEUKAEMIA |
27 |
0.0029 |
| 546 |
MYELOSUPPRESSION |
103 |
0.0029 |
| 547 |
ENCEPHALOPATHY |
70 |
0.0028 |
| 548 |
NECROTISING FASCIITIS |
10 |
0.0028 |
| 549 |
ENTERITIS |
18 |
0.0028 |
| 550 |
GRANULOCYTOPENIA |
16 |
0.0028 |
| 551 |
NEUROLOGICAL SYMPTOM |
16 |
0.0028 |
| 552 |
DERMATITIS BULLOUS |
20 |
0.0028 |
| 553 |
SQUAMOUS CELL CARCINOMA |
26 |
0.0028 |
| 554 |
HEPATITIS FULMINANT |
8 |
0.0027 |
| 555 |
LEFT VENTRICULAR DYSFUNCTION |
18 |
0.0027 |
| 556 |
DEMYELINATION |
11 |
0.0027 |
| 557 |
MALABSORPTION |
14 |
0.0027 |
| 558 |
ATYPICAL PNEUMONIA |
8 |
0.0027 |
| 559 |
CLOSTRIDIUM DIFFICILE INFECTION |
58 |
0.0027 |
| 560 |
PNEUMONITIS |
72 |
0.0026 |
| 561 |
LYMPHADENOPATHY |
93 |
0.0026 |
| 562 |
HYPERPYREXIA |
11 |
0.0026 |
| 563 |
DIFFUSE LARGE B-CELL LYMPHOMA |
20 |
0.0026 |
| 564 |
TOXIC EPIDERMAL NECROLYSIS |
39 |
0.0026 |
| 565 |
DIARRHOEA HAEMORRHAGIC |
24 |
0.0026 |
| 566 |
TRANSAMINASES INCREASED |
57 |
0.0026 |
| 567 |
LOSS OF THERAPEUTIC RESPONSE |
8 |
0.0025 |
| 568 |
PLEURAL EFFUSION |
152 |
0.0025 |
| 569 |
STUPOR |
8 |
0.0025 |
| 570 |
PARTIAL SEIZURES |
13 |
0.0025 |
| 571 |
JOINT EFFUSION |
17 |
0.0025 |
| 572 |
EJECTION FRACTION DECREASED |
38 |
0.0024 |
| 573 |
SKIN HYPERPIGMENTATION |
21 |
0.0024 |
| 574 |
DEAFNESS NEUROSENSORY |
8 |
0.0024 |
| 575 |
MYOPATHY |
21 |
0.0024 |
| 576 |
ORAL CANDIDIASIS |
32 |
0.0024 |
| 577 |
OTITIS MEDIA |
8 |
0.0024 |
| 578 |
ABDOMINAL TENDERNESS |
12 |
0.0024 |
| 579 |
RESPIRATORY DISORDER |
72 |
0.0024 |
| 580 |
OFF LABEL USE |
2098 |
0.0024 |
| 581 |
PYREXIA |
827 |
0.0024 |
| 582 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
70 |
0.0024 |
| 583 |
HYPOXIA |
84 |
0.0024 |
| 584 |
HYPERTHERMIA |
18 |
0.0024 |
| 585 |
HEPATIC PAIN |
10 |
0.0023 |
| 586 |
PROCTALGIA |
15 |
0.0023 |
| 587 |
LEFT VENTRICULAR FAILURE |
8 |
0.0023 |
| 588 |
INTENTIONAL PRODUCT USE ISSUE |
202 |
0.0023 |
| 589 |
CARDIOMYOPATHY |
34 |
0.0023 |
| 590 |
SERUM FERRITIN INCREASED |
12 |
0.0023 |
| 591 |
DISEASE RECURRENCE |
108 |
0.0023 |
| 592 |
CEREBRAL ATROPHY |
9 |
0.0023 |
| 593 |
DISEASE PROGRESSION |
267 |
0.0023 |
| 594 |
HEPATIC ENCEPHALOPATHY |
21 |
0.0022 |
| 595 |
MENINGITIS |
15 |
0.0022 |
| 596 |
MALNUTRITION |
25 |
0.0022 |
| 597 |
SUSPECTED OFF LABEL USE |
10 |
0.0022 |
| 598 |
CARDIOMEGALY |
27 |
0.0022 |
| 599 |
ODYNOPHAGIA |
13 |
0.0022 |
| 600 |
POLYNEUROPATHY |
26 |
0.0022 |
| 601 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
48 |
0.0022 |
| 602 |
VIRAL INFECTION |
72 |
0.0022 |
| 603 |
IMMUNOSUPPRESSION |
19 |
0.0022 |
| 604 |
ADRENAL INSUFFICIENCY |
26 |
0.0021 |
| 605 |
ACUTE PULMONARY OEDEMA |
12 |
0.0021 |
| 606 |
TACHYPNOEA |
29 |
0.0021 |
| 607 |
CHOLECYSTITIS ACUTE |
12 |
0.0021 |
| 608 |
INTERSTITIAL LUNG DISEASE |
102 |
0.0021 |
| 609 |
RETINAL HAEMORRHAGE |
15 |
0.0021 |
| 610 |
NEUTROPENIC SEPSIS |
15 |
0.0021 |
| 611 |
AGRANULOCYTOSIS |
39 |
0.0021 |
| 612 |
OLIGURIA |
13 |
0.0021 |
| 613 |
MENTAL STATUS CHANGES |
58 |
0.0021 |
| 614 |
NYSTAGMUS |
11 |
0.0021 |
| 615 |
SUBARACHNOID HAEMORRHAGE |
21 |
0.0021 |
| 616 |
SKIN LESION |
56 |
0.0020 |
| 617 |
TUBULOINTERSTITIAL NEPHRITIS |
38 |
0.0020 |
| 618 |
HYPERTRANSAMINASAEMIA |
14 |
0.0020 |
| 619 |
OESOPHAGEAL CANDIDIASIS |
8 |
0.0020 |
| 620 |
LUNG DISORDER |
98 |
0.0020 |
| 621 |
HEPATITIS |
51 |
0.0020 |
| 622 |
HEPATITIS B |
12 |
0.0020 |
| 623 |
C-REACTIVE PROTEIN INCREASED |
72 |
0.0020 |
| 624 |
HEPATOCELLULAR INJURY |
28 |
0.0020 |
| 625 |
ACUTE KIDNEY INJURY |
302 |
0.0020 |
| 626 |
SKIN MASS |
13 |
0.0019 |
| 627 |
CEREBRAL ISCHAEMIA |
10 |
0.0019 |
| 628 |
HEPATIC STEATOSIS |
36 |
0.0019 |
| 629 |
CHOLECYSTITIS |
23 |
0.0019 |
| 630 |
PERIORBITAL OEDEMA |
10 |
0.0019 |
| 631 |
OESOPHAGITIS |
21 |
0.0019 |
| 632 |
PULSELESS ELECTRICAL ACTIVITY |
8 |
0.0019 |
| 633 |
HAEMODIALYSIS |
16 |
0.0019 |
| 634 |
RENAL IMPAIRMENT |
160 |
0.0019 |
| 635 |
HEPATIC FUNCTION ABNORMAL |
71 |
0.0019 |
| 636 |
HALLUCINATIONS, MIXED |
8 |
0.0019 |
| 637 |
CEREBRAL HAEMORRHAGE |
68 |
0.0019 |
| 638 |
LUNG NEOPLASM |
8 |
0.0019 |
| 639 |
THERAPY NON-RESPONDER |
84 |
0.0019 |
| 640 |
MELAENA |
41 |
0.0019 |
| 641 |
HEPATITIS ACUTE |
12 |
0.0018 |
| 642 |
HYDROCEPHALUS |
10 |
0.0018 |
| 643 |
RENAL FAILURE |
243 |
0.0018 |
| 644 |
PULMONARY OEDEMA |
81 |
0.0018 |
| 645 |
ELECTROLYTE IMBALANCE |
21 |
0.0018 |
| 646 |
HYPERNATRAEMIA |
9 |
0.0018 |
| 647 |
CYTOKINE RELEASE SYNDROME |
36 |
0.0018 |
| 648 |
BLOOD UREA INCREASED |
30 |
0.0018 |
| 649 |
COVID-19 PNEUMONIA |
21 |
0.0018 |
| 650 |
ASPARTATE AMINOTRANSFERASE INCREASED |
94 |
0.0018 |
| 651 |
ALANINE AMINOTRANSFERASE INCREASED |
108 |
0.0018 |
| 652 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
13 |
0.0018 |
| 653 |
ACUTE HEPATIC FAILURE |
24 |
0.0018 |
| 654 |
CARDIOGENIC SHOCK |
24 |
0.0017 |
| 655 |
JAUNDICE |
45 |
0.0017 |
| 656 |
MOTOR DYSFUNCTION |
17 |
0.0017 |
| 657 |
CYSTITIS |
53 |
0.0017 |
| 658 |
TORSADE DE POINTES |
13 |
0.0017 |
| 659 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
18 |
0.0016 |
| 660 |
HYPOPHOSPHATAEMIA |
12 |
0.0016 |
| 661 |
SUBDURAL HAEMATOMA |
23 |
0.0016 |
| 662 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
37 |
0.0016 |
| 663 |
AUTOIMMUNE HEPATITIS |
11 |
0.0016 |
| 664 |
PROTEINURIA |
30 |
0.0016 |
| 665 |
HYPERTENSION |
333 |
0.0016 |
| 666 |
ACIDOSIS |
12 |
0.0016 |
| 667 |
PNEUMONIA |
505 |
0.0016 |
| 668 |
SKIN NECROSIS |
8 |
0.0015 |
| 669 |
ILEUS |
19 |
0.0015 |
| 670 |
VISUAL FIELD DEFECT |
11 |
0.0015 |
| 671 |
GASTROINTESTINAL HAEMORRHAGE |
127 |
0.0015 |
| 672 |
LIVER FUNCTION TEST ABNORMAL |
44 |
0.0015 |
| 673 |
CARDIAC FAILURE ACUTE |
10 |
0.0015 |
| 674 |
MOUTH HAEMORRHAGE |
11 |
0.0015 |
| 675 |
HAEMATEMESIS |
38 |
0.0015 |
| 676 |
SEIZURE |
173 |
0.0015 |
| 677 |
HYPERCALCAEMIA |
18 |
0.0015 |
| 678 |
STREPTOCOCCAL INFECTION |
8 |
0.0014 |
| 679 |
RENAL TUBULAR NECROSIS |
14 |
0.0014 |
| 680 |
FRACTURE |
27 |
0.0014 |
| 681 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
35 |
0.0014 |
| 682 |
MYOCARDITIS |
16 |
0.0014 |
| 683 |
GENERALISED TONIC-CLONIC SEIZURE |
23 |
0.0014 |
| 684 |
DRUG LEVEL INCREASED |
23 |
0.0014 |
| 685 |
ALTERED STATE OF CONSCIOUSNESS |
30 |
0.0014 |
| 686 |
ABSCESS |
22 |
0.0014 |
| 687 |
RALES |
8 |
0.0014 |
| 688 |
FLUID OVERLOAD |
20 |
0.0014 |
| 689 |
HYPERTRIGLYCERIDAEMIA |
8 |
0.0014 |
| 690 |
HYPOMAGNESAEMIA |
19 |
0.0014 |
| 691 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
8 |
0.0013 |
| 692 |
ATAXIA |
16 |
0.0013 |
| 693 |
HYPERCHOLESTEROLAEMIA |
13 |
0.0013 |
| 694 |
MYOCLONUS |
16 |
0.0013 |
| 695 |
SKIN INFECTION |
15 |
0.0013 |
| 696 |
MOUTH ULCERATION |
28 |
0.0013 |
| 697 |
OSTEONECROSIS |
43 |
0.0013 |
| 698 |
DIPLOPIA |
34 |
0.0013 |
| 699 |
GRAND MAL CONVULSION |
12 |
0.0013 |
| 700 |
HYPOPHAGIA |
33 |
0.0013 |
| 701 |
FACIAL PARALYSIS |
11 |
0.0013 |
| 702 |
APNOEA |
10 |
0.0013 |
| 703 |
HYPOTHYROIDISM |
41 |
0.0013 |
| 704 |
ORAL HERPES |
25 |
0.0013 |
| 705 |
ANURIA |
11 |
0.0013 |
| 706 |
NEOPLASM PROGRESSION |
44 |
0.0013 |
| 707 |
BLOOD ALBUMIN DECREASED |
10 |
0.0013 |
| 708 |
VENTRICULAR FIBRILLATION |
14 |
0.0013 |
| 709 |
HERPES ZOSTER |
72 |
0.0013 |
| 710 |
PULMONARY FIBROSIS |
24 |
0.0012 |
| 711 |
TUMOUR LYSIS SYNDROME |
11 |
0.0012 |
| 712 |
EPILEPSY |
38 |
0.0012 |
| 713 |
DERMATITIS |
26 |
0.0012 |
| 714 |
TOXICITY TO VARIOUS AGENTS |
209 |
0.0012 |
| 715 |
ANAEMIA |
235 |
0.0012 |
| 716 |
DYSGRAPHIA |
8 |
0.0012 |
| 717 |
LIVER FUNCTION TEST INCREASED |
26 |
0.0012 |
| 718 |
CARDIAC FAILURE |
97 |
0.0012 |
| 719 |
CONVULSION |
68 |
0.0012 |
| 720 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
20 |
0.0012 |
| 721 |
APPENDICITIS |
11 |
0.0012 |
| 722 |
SHOCK |
27 |
0.0012 |
| 723 |
LIVER DISORDER |
52 |
0.0012 |
| 724 |
HYPERLIPIDAEMIA |
14 |
0.0012 |
| 725 |
OBSTRUCTIVE AIRWAYS DISORDER |
13 |
0.0012 |
| 726 |
HEPATITIS C |
14 |
0.0012 |
| 727 |
CARDIO-RESPIRATORY ARREST |
48 |
0.0011 |
| 728 |
GLOMERULAR FILTRATION RATE DECREASED |
14 |
0.0011 |
| 729 |
PLATELET COUNT DECREASED |
121 |
0.0011 |
| 730 |
DUODENAL ULCER |
8 |
0.0011 |
| 731 |
PERICARDITIS |
19 |
0.0011 |
| 732 |
GASTRIC HAEMORRHAGE |
13 |
0.0011 |
| 733 |
NEUTROPHIL COUNT DECREASED |
46 |
0.0011 |
| 734 |
AUTOIMMUNE DISORDER |
11 |
0.0011 |
| 735 |
CIRCULATORY COLLAPSE |
19 |
0.0011 |
| 736 |
DRUG-INDUCED LIVER INJURY |
35 |
0.0011 |
| 737 |
ASPIRATION |
12 |
0.0011 |
| 738 |
ANOREXIA |
14 |
0.0011 |
| 739 |
COLITIS |
41 |
0.0011 |
| 740 |
IMMUNODEFICIENCY |
16 |
0.0011 |
| 741 |
RENAL DISORDER |
50 |
0.0011 |
| 742 |
ISCHAEMIC STROKE |
19 |
0.0011 |
| 743 |
REBOUND EFFECT |
12 |
0.0011 |
| 744 |
RENAL FAILURE ACUTE |
45 |
0.0011 |
| 745 |
HYPOCALCAEMIA |
20 |
0.0011 |
| 746 |
RESPIRATORY TRACT INFECTION |
27 |
0.0010 |
| 747 |
STEVENS-JOHNSON SYNDROME |
23 |
0.0010 |
| 748 |
HEPATIC ENZYME INCREASED |
70 |
0.0010 |
| 749 |
TREATMENT FAILURE |
85 |
0.0010 |
| 750 |
OEDEMA |
55 |
0.0010 |
| 751 |
PULMONARY MASS |
15 |
0.0010 |
| 752 |
LEUKOCYTOSIS |
18 |
0.0010 |
| 753 |
BLOOD COUNT ABNORMAL |
15 |
0.0010 |
| 754 |
HYPERGLYCAEMIA |
36 |
0.0010 |
| 755 |
DIALYSIS |
14 |
0.0010 |
| 756 |
LIVER INJURY |
24 |
0.0010 |
| 757 |
EPISTAXIS |
73 |
0.0010 |
| 758 |
HAEMORRHAGE |
102 |
0.0010 |
| 759 |
BLOOD CREATININE INCREASED |
63 |
0.0010 |
| 760 |
RASH ERYTHEMATOUS |
46 |
0.0010 |
| 761 |
GASTROENTERITIS |
14 |
0.0010 |
| 762 |
POST PROCEDURAL HAEMORRHAGE |
11 |
0.0009 |
| 763 |
METABOLIC ACIDOSIS |
30 |
0.0009 |
| 764 |
HAEMOPTYSIS |
26 |
0.0009 |
| 765 |
DYSURIA |
34 |
0.0009 |
| 766 |
DRUG INTOLERANCE |
88 |
0.0009 |
| 767 |
BLINDNESS |
37 |
0.0009 |
| 768 |
LYMPHOMA |
14 |
0.0009 |
| 769 |
IMPAIRED QUALITY OF LIFE |
13 |
0.0009 |
| 770 |
MENINGIOMA |
14 |
0.0009 |
| 771 |
INFLAMMATION |
46 |
0.0009 |
| 772 |
UPPER RESPIRATORY TRACT INFECTION |
41 |
0.0009 |
| 773 |
DRUG LEVEL DECREASED |
9 |
0.0009 |
| 774 |
HIDRADENITIS |
8 |
0.0009 |
| 775 |
NERVOUS SYSTEM DISORDER |
27 |
0.0009 |
| 776 |
RECTAL HAEMORRHAGE |
37 |
0.0009 |
| 777 |
EYELID OEDEMA |
10 |
0.0009 |
| 778 |
THERAPEUTIC RESPONSE DECREASED |
52 |
0.0009 |
| 779 |
AMENORRHOEA |
15 |
0.0009 |
| 780 |
CELLULITIS |
43 |
0.0009 |
| 781 |
HYPOKALAEMIA |
39 |
0.0008 |
| 782 |
GASTROINTESTINAL DISORDER |
74 |
0.0008 |
| 783 |
DRUG INEFFECTIVE |
1088 |
0.0008 |
| 784 |
NO THERAPEUTIC RESPONSE |
10 |
0.0008 |
| 785 |
SMALL INTESTINAL OBSTRUCTION |
10 |
0.0008 |
| 786 |
CARDIAC ARREST |
67 |
0.0008 |
| 787 |
TOOTH DISORDER |
18 |
0.0008 |
| 788 |
DRUG INTERACTION |
128 |
0.0008 |
| 789 |
BLADDER DISORDER |
8 |
0.0008 |
| 790 |
EYELID PTOSIS |
8 |
0.0008 |
| 791 |
DIARRHOEA |
503 |
0.0008 |
| 792 |
INTERVERTEBRAL DISC PROTRUSION |
17 |
0.0008 |
| 793 |
PRODUCT USE ISSUE |
146 |
0.0008 |
| 794 |
FACE OEDEMA |
13 |
0.0008 |
| 795 |
FOLLICULITIS |
8 |
0.0008 |
| 796 |
MALIGNANT NEOPLASM PROGRESSION |
78 |
0.0008 |
| 797 |
IMMUNE SYSTEM DISORDER |
10 |
0.0008 |
| 798 |
CONJUNCTIVITIS |
14 |
0.0008 |
| 799 |
QUALITY OF LIFE DECREASED |
10 |
0.0007 |
| 800 |
LEUKOPENIA |
37 |
0.0007 |
| 801 |
BIPOLAR DISORDER |
8 |
0.0007 |
| 802 |
CENTRAL NERVOUS SYSTEM LESION |
10 |
0.0007 |
| 803 |
ABDOMINAL PAIN |
166 |
0.0007 |
| 804 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
28 |
0.0007 |
| 805 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
9 |
0.0007 |
| 806 |
HEPATIC CIRRHOSIS |
13 |
0.0007 |
| 807 |
PLATELET COUNT INCREASED |
9 |
0.0007 |
| 808 |
PNEUMONIA ASPIRATION |
17 |
0.0007 |
| 809 |
DEEP VEIN THROMBOSIS |
44 |
0.0007 |
| 810 |
SKIN HAEMORRHAGE |
10 |
0.0007 |
| 811 |
MALIGNANT MELANOMA |
9 |
0.0007 |
| 812 |
APHASIA |
20 |
0.0007 |
| 813 |
HAEMATOMA |
17 |
0.0007 |
| 814 |
DISORIENTATION |
26 |
0.0007 |
| 815 |
CEREBRAL INFARCTION |
16 |
0.0007 |
| 816 |
FLUID RETENTION |
33 |
0.0006 |
| 817 |
GENERAL PHYSICAL HEALTH DETERIORATION |
75 |
0.0006 |
| 818 |
SINUS TACHYCARDIA |
9 |
0.0006 |
| 819 |
ORAL PAIN |
14 |
0.0006 |
| 820 |
CATARACT |
37 |
0.0006 |
| 821 |
NEOPLASM MALIGNANT |
41 |
0.0006 |
| 822 |
COMA |
29 |
0.0006 |
| 823 |
OXYGEN SATURATION DECREASED |
34 |
0.0006 |
| 824 |
URINARY TRACT INFECTION |
103 |
0.0006 |
| 825 |
NEUROPATHY PERIPHERAL |
57 |
0.0006 |
| 826 |
PRODUCT PRESCRIBING ISSUE |
13 |
0.0006 |
| 827 |
FULL BLOOD COUNT DECREASED |
12 |
0.0006 |
| 828 |
HYPONATRAEMIA |
33 |
0.0006 |
| 829 |
ATRIAL FIBRILLATION |
57 |
0.0006 |
| 830 |
DELIRIUM |
20 |
0.0006 |
| 831 |
POST PROCEDURAL COMPLICATION |
11 |
0.0006 |
| 832 |
WHITE BLOOD CELL COUNT DECREASED |
62 |
0.0006 |
| 833 |
COVID-19 |
100 |
0.0006 |
| 834 |
HAEMOGLOBIN DECREASED |
58 |
0.0006 |
| 835 |
HYPOTENSION |
113 |
0.0006 |
| 836 |
DRY EYE |
28 |
0.0006 |
| 837 |
PALLOR |
15 |
0.0006 |
| 838 |
PLASMA CELL MYELOMA |
21 |
0.0005 |
| 839 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
38 |
0.0005 |
| 840 |
GASTRITIS |
14 |
0.0005 |
| 841 |
HEMIPARESIS |
9 |
0.0005 |
| 842 |
TACHYCARDIA |
47 |
0.0005 |
| 843 |
VOMITING |
244 |
0.0005 |
| 844 |
MUSCULOSKELETAL CHEST PAIN |
8 |
0.0005 |
| 845 |
HYPERKALAEMIA |
18 |
0.0005 |
| 846 |
THROMBOSIS |
41 |
0.0005 |
| 847 |
RESPIRATORY ARREST |
14 |
0.0005 |
| 848 |
DYSPHAGIA |
48 |
0.0005 |
| 849 |
UNRESPONSIVE TO STIMULI |
13 |
0.0005 |
| 850 |
PRODUCTIVE COUGH |
24 |
0.0005 |
| 851 |
WEIGHT INCREASED |
112 |
0.0005 |
| 852 |
DEAFNESS |
13 |
0.0005 |
| 853 |
OEDEMA PERIPHERAL |
60 |
0.0005 |
| 854 |
PANCREATITIS ACUTE |
11 |
0.0005 |
| 855 |
CONDITION AGGRAVATED |
148 |
0.0005 |
| 856 |
OSTEOPOROSIS |
20 |
0.0005 |
| 857 |
PERITONITIS |
10 |
0.0005 |
| 858 |
PSYCHOMOTOR HYPERACTIVITY |
8 |
0.0005 |
| 859 |
URINARY RETENTION |
16 |
0.0005 |
| 860 |
DYSPNOEA EXERTIONAL |
18 |
0.0005 |
| 861 |
FOOT FRACTURE |
9 |
0.0005 |
| 862 |
HALLUCINATION, VISUAL |
10 |
0.0005 |
| 863 |
ELECTROCARDIOGRAM QT PROLONGED |
17 |
0.0005 |
| 864 |
CHRONIC KIDNEY DISEASE |
35 |
0.0005 |
| 865 |
EOSINOPHILIA |
8 |
0.0005 |
| 866 |
GALLBLADDER DISORDER |
8 |
0.0004 |
| 867 |
COUGH |
124 |
0.0004 |
| 868 |
INFLUENZA |
49 |
0.0004 |
| 869 |
ANAPHYLACTIC REACTION |
24 |
0.0004 |
| 870 |
RHINORRHOEA |
28 |
0.0004 |
| 871 |
CHILLS |
50 |
0.0004 |
| 872 |
BLOOD SODIUM DECREASED |
8 |
0.0004 |
| 873 |
AGITATION |
31 |
0.0004 |
| 874 |
RED BLOOD CELL COUNT DECREASED |
12 |
0.0004 |
| 875 |
HAEMATOCHEZIA |
23 |
0.0004 |
| 876 |
FAECES DISCOLOURED |
9 |
0.0004 |
| 877 |
ARTHROPATHY |
23 |
0.0004 |
| 878 |
CARDIAC FAILURE CONGESTIVE |
33 |
0.0004 |
| 879 |
PRODUCT ADMINISTRATION ERROR |
8 |
0.0004 |
| 880 |
FEEDING DISORDER |
8 |
0.0004 |
| 881 |
BODY TEMPERATURE INCREASED |
8 |
0.0004 |
| 882 |
SKIN EXFOLIATION |
33 |
0.0004 |
| 883 |
PULMONARY EMBOLISM |
37 |
0.0004 |
| 884 |
ABDOMINAL DISTENSION |
40 |
0.0004 |
| 885 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
11 |
0.0004 |
| 886 |
DEATH |
320 |
0.0004 |
| 887 |
NAUSEA |
289 |
0.0004 |
| 888 |
WHITE BLOOD CELL COUNT INCREASED |
14 |
0.0004 |
| 889 |
POLLAKIURIA |
15 |
0.0004 |
| 890 |
DECREASED APPETITE |
83 |
0.0004 |
| 891 |
RASH PAPULAR |
8 |
0.0004 |
| 892 |
DYSPNOEA |
200 |
0.0004 |
| 893 |
RASH PRURITIC |
19 |
0.0004 |
| 894 |
CONFUSIONAL STATE |
56 |
0.0003 |
| 895 |
LUNG NEOPLASM MALIGNANT |
14 |
0.0003 |
| 896 |
ARRHYTHMIA |
16 |
0.0003 |
| 897 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 898 |
WITHDRAWAL SYNDROME |
14 |
0.0003 |
| 899 |
DIABETIC KETOACIDOSIS |
8 |
0.0003 |
| 900 |
TREMOR |
55 |
0.0003 |
| 901 |
MUSCULAR WEAKNESS |
37 |
0.0003 |
| 902 |
NECK PAIN |
18 |
0.0003 |
| 903 |
OROPHARYNGEAL PAIN |
29 |
0.0003 |
| 904 |
LACTIC ACIDOSIS |
10 |
0.0003 |
| 905 |
ERYTHEMA |
63 |
0.0003 |
| 906 |
LOSS OF CONSCIOUSNESS |
39 |
0.0003 |
| 907 |
BRADYCARDIA |
16 |
0.0003 |
| 908 |
EYE PAIN |
17 |
0.0003 |
| 909 |
RASH |
128 |
0.0003 |
| 910 |
INTERNATIONAL NORMALISED RATIO INCREASED |
8 |
0.0003 |
| 911 |
ILL-DEFINED DISORDER |
17 |
0.0003 |
| 912 |
DRY MOUTH |
22 |
0.0003 |
| 913 |
SKIN DISORDER |
9 |
0.0003 |
| 914 |
PREMATURE BABY |
8 |
0.0003 |
| 915 |
DISTURBANCE IN ATTENTION |
14 |
0.0003 |
| 916 |
BLOOD PRESSURE DECREASED |
17 |
0.0003 |
| 917 |
HYPOACUSIS |
11 |
0.0003 |
| 918 |
ASTHENIA |
96 |
0.0003 |
| 919 |
DEHYDRATION |
34 |
0.0003 |
| 920 |
ABNORMAL BEHAVIOUR |
10 |
0.0003 |
| 921 |
VISUAL IMPAIRMENT |
31 |
0.0002 |
| 922 |
NIGHT SWEATS |
8 |
0.0002 |
| 923 |
HEADACHE |
154 |
0.0002 |
| 924 |
CHOLELITHIASIS |
8 |
0.0002 |
| 925 |
ALOPECIA |
46 |
0.0002 |
| 926 |
BLISTER |
13 |
0.0002 |
| 927 |
PARAESTHESIA |
34 |
0.0002 |
| 928 |
SINUSITIS |
22 |
0.0002 |
| 929 |
COGNITIVE DISORDER |
10 |
0.0002 |
| 930 |
MOBILITY DECREASED |
15 |
0.0002 |
| 931 |
PAIN |
128 |
0.0002 |
| 932 |
CHEST PAIN |
38 |
0.0002 |
| 933 |
BONE PAIN |
12 |
0.0002 |
| 934 |
VERTIGO |
12 |
0.0002 |
| 935 |
LETHARGY |
11 |
0.0002 |
| 936 |
PANCREATITIS |
10 |
0.0002 |
| 937 |
HALLUCINATION |
14 |
0.0002 |
| 938 |
CHEST DISCOMFORT |
19 |
0.0002 |
| 939 |
WHEEZING |
11 |
0.0002 |
| 940 |
TREATMENT NONCOMPLIANCE |
10 |
0.0002 |
| 941 |
BACK PAIN |
42 |
0.0002 |
| 942 |
EYE IRRITATION |
10 |
0.0002 |
| 943 |
FATIGUE |
135 |
0.0002 |
| 944 |
SPEECH DISORDER |
9 |
0.0002 |
| 945 |
DIABETES MELLITUS |
13 |
0.0002 |
| 946 |
IRRITABILITY |
10 |
0.0002 |
| 947 |
ABDOMINAL PAIN UPPER |
34 |
0.0002 |
| 948 |
DYSGEUSIA |
12 |
0.0002 |
| 949 |
HYPOAESTHESIA |
24 |
0.0002 |
| 950 |
AGGRESSION |
8 |
0.0002 |
| 951 |
WEIGHT DECREASED |
44 |
0.0002 |
| 952 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 953 |
DYSPHONIA |
9 |
0.0002 |
| 954 |
MUSCULOSKELETAL PAIN |
8 |
0.0002 |
| 955 |
VISION BLURRED |
20 |
0.0001 |
| 956 |
NO ADVERSE EVENT |
26 |
0.0001 |
| 957 |
SLEEP DISORDER |
10 |
0.0001 |
| 958 |
GAIT DISTURBANCE |
27 |
0.0001 |
| 959 |
INTENTIONAL PRODUCT MISUSE |
12 |
0.0001 |
| 960 |
PRURITUS |
52 |
0.0001 |
| 961 |
INSOMNIA |
36 |
0.0001 |
| 962 |
ARTHRALGIA |
56 |
0.0001 |
| 963 |
CONSTIPATION |
29 |
0.0001 |
| 964 |
MALAISE |
56 |
0.0001 |
| 965 |
ARTHRITIS |
10 |
0.0001 |
| 966 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 967 |
PALPITATIONS |
14 |
0.0001 |
| 968 |
UNEVALUABLE EVENT |
9 |
0.0001 |
| 969 |
HYPERHIDROSIS |
15 |
0.0001 |
| 970 |
MUSCLE SPASMS |
20 |
0.0001 |
| 971 |
HYPERSENSITIVITY |
20 |
0.0001 |
| 972 |
CEREBROVASCULAR ACCIDENT |
18 |
0.0001 |
| 973 |
DRY SKIN |
14 |
0.0001 |
| 974 |
GASTROOESOPHAGEAL REFLUX DISEASE |
8 |
0.0001 |
| 975 |
SOMNOLENCE |
20 |
0.0001 |
| 976 |
ADVERSE EVENT |
9 |
0.0001 |
| 977 |
CARDIAC DISORDER |
9 |
0.0001 |
| 978 |
FALL |
31 |
0.0001 |
| 979 |
PAIN IN EXTREMITY |
27 |
0.0001 |
| 980 |
DIZZINESS |
38 |
0.0001 |
| 981 |
MYOCARDIAL INFARCTION |
13 |
0.0001 |
| 982 |
ANXIETY |
21 |
0.0001 |
| 983 |
MYALGIA |
12 |
0.0001 |
| 984 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 985 |
OVERDOSE |
13 |
0.0001 |
| 986 |
DEPRESSION |
12 |
0.0001 |
| 987 |
NASOPHARYNGITIS |
9 |
0.0000 |
| 988 |
ABDOMINAL DISCOMFORT |
8 |
0.0000 |
| 989 |
FEELING ABNORMAL |
11 |
0.0000 |